Beryl Drugs Q2 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
23.04
-1.21 (-4.99%)
-1.21 (-4.99%)Volume124.00
Updated: Thu 11 Jun, 2026 | 15:44:21
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4.82 | 4.67 | 3.23% | 5.41 | -11.06% |
| Depreciation/ Amortization | 0.39 | 0.38 | 2.81% | 0.33 | 16.94% |
| Operating Income | 0.30 | 0.13 | 135.40% | 0.20 | 52.48% |
| Net Income | 0.01 | 0.02 | -57.82% | 0.01 | 28.99% |
| Other Operating Expenses Total | 1.27 | 1.73 | -26.59% | 1.90 | -33.27% |
| Net Income Before Taxes | 0.26 | 0.07 | 273.46% | 0.11 | 141.69% |
| Total Revenue | 5.12 | 4.79 | 6.79% | 5.61 | -8.80% |
| Selling/ General/ Admin Expenses Total | 0.58 | 0.53 | 8.04% | 0.50 | 15.06% |
| Diluted Normalized EPS | 0.02 | 0.04 | -52.90% | 0.01 | 38.53% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.